Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates

被引:12
|
作者
Di Lullo, Giulia [1 ,2 ]
Marcatti, Magda [3 ]
Protti, Maria Pia [1 ,2 ]
机构
[1] Ist Sci San Raffaele, IRCCS, Tumor Immunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, IRCCS, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy
来源
ONCOIMMUNOLOGY | 2016年 / 5卷 / 04期
关键词
BM mesenchymal stromal cells; BM microenvironment; bone disease; disease prognosis; IL-13; IL-17; IL-22; multiple myeloma; Th17; cells; Th22; DENDRITIC CELLS; INTERLEUKIN; 22; BONE-DISEASE; IDENTIFICATION; SUBSET; T(H)17; MARROW; IMMUNE; IL-17;
D O I
10.1080/2162402X.2015.1093278
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We recently reported that in multiple myeloma increased Th22 cell frequencies correlate with poor prognosis. Here we show that within the same patients' cohort Th17 cells associate with bone disease and not with prognosis. Thus, we propose that Th22 and Th17 cells play non-redundant roles in multiple myeloma and constitute independent therapeutic targets.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis
    Fu, Dandan
    Song, Xiangfeng
    Hu, Hua
    Sun, Min
    Li, Zhanguo
    Tian, Zhongwei
    MOLECULAR MEDICINE REPORTS, 2016, 13 (06) : 4606 - 4612
  • [42] IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behcet's disease
    Cetin, Esin Aktas
    Cosan, Fulya
    Cefle, Ayse
    Deniz, Gunnur
    MODERN RHEUMATOLOGY, 2014, 24 (05) : 802 - 807
  • [43] Level changes and clinical significance of peripheral blood Th22 and Th17 cells in septic patients with acute lung injury
    Chen, Jiancheng
    Liu, Zhimin
    Chen, Junhuang
    Shen, Mugui
    Zhu, Jiahua
    PANMINERVA MEDICA, 2022, 64 (03) : 401 - 402
  • [44] A High Frequency of Circulating Th22 and Th17 Cells in Patients with New Onset Graves' Disease
    Peng, Di
    Xu, Bingchuan
    Wang, Ye
    Guo, Hui
    Jiang, Yanfang
    PLOS ONE, 2013, 8 (07):
  • [45] Sustained response following withdrawal of guselkumab treatment correlates with reduced Th17 and Th22 effector cytokine levels
    Branigan, P.
    Liu, X.
    Chen, Y.
    Scott, B.
    Yao, Z.
    Li, S.
    Wasfi, Y.
    Song, M.
    Campbell, K.
    Munoz-Elias, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S194 - S194
  • [46] The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
    Braga, Walter M. T.
    Atanackovic, Djordje
    Colleoni, Gisele W. B.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [47] Involvement Of Polycyclic Aromatic Hydrocarbons In Th22/Th17 Polarization In Allergic Diseases
    Ple, C.
    Fan, Y.
    Vorng, H.
    Azzaoui, I.
    Yahia, S. Ait
    Lazennec, G.
    Wallaert, B.
    Tsicopoulos, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB196 - AB196
  • [48] The Alteration and Clinical Significance of Th1/Th2/Th17/Treg Cells in Patients with Multiple Myeloma
    Ping Feng
    Ruhong Yan
    Xiaoli Dai
    Xiaofang Xie
    Huiyan Wen
    Shun Yang
    Inflammation, 2015, 38 : 705 - 709
  • [49] The Alteration and Clinical Significance of Th1/Th2/Th17/Treg Cells in Patients with Multiple Myeloma
    Feng, Ping
    Yan, Ruhong
    Dai, Xiaoli
    Xie, Xiaofang
    Wen, Huiyan
    Yang, Shun
    INFLAMMATION, 2015, 38 (02) : 705 - 709
  • [50] Dust mite potently activates Th17/Th22 pathways and models multiple inflammatory skin conditions in humans
    Malik, K.
    Ungar, B.
    Garcet, S.
    Dutt, R.
    Suarez-Farinas, M.
    Shemer, A.
    Krueger, J. G.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S119 - S119